- 12-month maternity cover for Jade Marshall - Sit in the Patient Access and Value team, but working cross-functionally within the EU/INT region and globally- Cover medicines across the rare disease, oncology and neurology space including market sizing and epidemiology, due diligence on prospective products, early to advanced pipeline planning, and life cycle management for existing products

Joined Jazz on its ‘high value employee’ retention scheme following its acquisition of GW Pharmaceuticals – my previous function was split into four and I chose to join Public Policy, heading up the ex-US region and leading on cannabis policy within the US, but still working across the breadth of comms. Cover global, regional (EU institutions) and country-level public policy and external affairs strategy across the full portfolio of Jazz medicines and pipeline within rare disease, cannabinoids, neurology and oncology. Working closely with Patient Advocacy and Communications, tasked with identifying and addressing barriers facing approval and uptake of our medicines and developing thought leadership opportunities to promote and differentiate them and Jazz externally.Cover corporate / cross-portfolio public policy issues of significance to Jazz, including intellectual property and incentives, access and pricing, health data, and regional disease strategies – notably including negotiations around the EU Pharma Package, EU AI Act, HTA Regulation (EU), VPAG (UK) and US Inflation Reduction Act. Brief the CEO and SVP, Head of Europe and International, and UK General Manager ahead of EFPIA, EUCOPE, ABPI and BIO meetings, and represent the company on key working groups. Lead company strategy, engagement and education on cannabis control and scheduling matters, including engagement with the INCB, UNODC and WHO, alongside national controlled drug authorities such as the UK Home Office. Presented at two UN Commission on Narcotic Drug annual meetings on cannabis control issues. Additional global engagement work - UN, WHO etc - focused on neurological conditions. Demonstrable ability to work effectively cross-functionally on a national, regional and global level across brands (sit on two regional core brand teams), regularly being tasked to work on business-critical projects outside my primary remit e.g. diagnostics strategy, life cycle management.

GW Pharmaceuticals (GW) was a cutting-edge UK-based biopharmaceutical company that over two decades established a world-leading position in cannabinoid science and the development of regulatory approved cannabis-based medicines.In October 2018, TIME magazine named GW one of the 'Top 50 Genius Companies of 2018 That Are Inventing the Future' and in 2021 GW was awarded the Queen’s Award for Innovation. Joined GW initially on secondment from FTI and was tasked with establishing the external affairs function outside of the US, including the UK, EU markets (including Brussels), Canada, Australia, Israel, Japan, South Korea, Taiwan, Israel, Brazil and Mexico. Responsibilities and achievements included: - Leading external communications around the FDA and EMA approval and launch of new medicines resulting in extensive multi-market high-profile and positive media coverage - Working closely with the VP Investor Relations and Exec team to develop and promote the company’s story and value proposition - Developing and leading educational initiatives explaining cannabinoid science and medicines, including the value of the medicines approval process - representing the company at the World Economic Forum (2020) and various UN meetings including UNODC annual meetings (March 2020 and 2022, including presentations at the 2020 event).- Reactive and proactive media relations, with 100s of top tier positive print and broadcast media secured (many standalone company features), including The Times, Guardian, FT, Bloomberg, Daily Mail, CNN, BBC News (various times and formats) and Breakfast, Sky News, ITV News, One Show, Countryfile, NY Times, WSJ, The Lancet, Wired, New Scientist, Newsnight - Developed and enacted government and regulatory engagement strategies to reduce market and patient access barriers, including the rescheduling of GW medicinesRegularly worked on projects outside of my primary communications remit – often reporting into the Chairman, CEO and COO.

Headed up the Health and Life Sciences practice within the Public Affairs team – primarily focused on policy, political, regulatory and crisis communications activities, but often heading up cross-functional teams and campaigns spanning the whole of strategic communications (investor relations, corporate, healthcare communications and HTA submissions). Generally working closely with and advising Executive teams, Boards and CEOs. UK, EU-wide, US and global work, including coordination and management of in-country teams across all major markets. Represented healthcare clients including GW, Gilead, Shire, Takeda, Smith and Nephew, Cinven (its portfolio of healthcare investments), Concordia International, Virgin Care, Centene, Compass Pathways and IQVIA. Non-healthcare retained clients included Vanguard Asset Management (leading all EU-wide work), JP Morgan, Macquarie and IG Group. Established and led the PA team’s internal training and development initiatives – directly line managing five people and serving as a formal mentor for four across the division.

Board member, Tower Hamlets, Hackney and Redbridge Further Education Colleges (now New City College) – oversaw the merger of the three colleges in 2016. Stood down due to work travel requirements.

• Led the 40-strong company’s strategic communications work and a team of ten consultants, alongside wider work in public affairs – focus on integrated campaigning.• Winner of the Public Affairs Awards’ Consultant of the Year 2015 for campaigns developed for Cystic Fibrosis Trust (extension of the Rare Conditions Medicines Fund in Scotland and Humira access issues), Parkinson’s UK (awareness raising and advocacy around the disease), BIA and AbbVie.• Additional clients including Akzo Nobel, Dulux, Octopus, Visa, JustEat, AQA (biggest exam board), Association of School and College Leaders (ASCL), King’s College and LSE. • Started at Account Manager level and quickly progressed up due to particularly strong new business/sales and management capabilities.

Worked for various Hospital Trusts and Clinical Commissioning Groups to assess healthcare needs of local populations and develop specifications for new services to be commissioned – focus on child and maternity services. Whilst studying postgraduate at Oxford University.

Monitoring and evaluation of local NGOs ahead of funding being released for a five year, 9 million Euros, ‘Transitions in the East Alliance’ project focused on mental health, disability and child health issues.

Worked with the organisation to apply for UNAIDS funding, raise their profile, expand the services offered to women and children, encourage more referrals, and develop a regional advocacy network for women. Work across Central Asia.

Clients and campaigns across the healthcare sector including for Cancer Research UK (successful campaign to ban sunbeds for under 18s and development of the Cancer Drugs Fund) and the BioIndustry Association (BIA).

Ran a successful campaign to re-elect Kate Hoey to Parliament and secure Lambeth Council for Labour, alongside support on other campaigns.

Research, writing and editing features, news and comment pieces for consumer and trade publications including Oil and Gas Middle East, Petrochemicals Middle East, Arabian Business, Timeout Dubai, Timeout Annual Guides (Oman edition) and Harper's Bazaar.

Researched and publicised the cases of imprisoned journalists to national and international audiences, including the OSCE, European Union, United States and British embassies.

Stakeholder/political engagement work, including organising events and media coverage, to publicise the programme and human rights abuses within Iran.

• Prepared issue briefings for the Senator’s office and the Senate Committee on Foreign Relations, which Biden chaired at the time. • Took tours of the Senate and answered constituent correspondence.

Media monitoring, press release drafting, fielding press calls, preparing policy briefings and new business approaches.

Assessed the health and social needs of local communities and reported to commissioners.